Influence of neprilysin inhibition on the efficacy and safety of empagliflozin in patients with chronic heart failure and a reduced ejection fraction: the EMPEROR-Reduced trial - Packer, Milton; Anker, Stefan D; Butler, Javed; Filippatos, Gerasimos; Ferreira, Joao Pedro; Pocock, Stuart J; Rocca, Hans-Peter Brunner-La; Janssens, Stefan; Tsutsui, Hiroyuki; Zhang, Jian; Brückmann, Martina; Jamal, Waheed; et al. (European heart journal, 2021)
Gesehen am 31.05.2021